Talk:Phenprocoumon

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Phenprocoumon. PubMed provides review articles from the past five years (limit to free review articles) The TRIP database provides clinical publications about evidence-based medicine. Other potential sources include: Centre for Reviews and Dissemination and CDC

A fact from Phenprocoumon appeared on Wikipedia's Main Page in the Did you know column on 2 September 2021 (check views). The text of the entry was as follows: Did you know... that taking St John's wort can weaken the effects of the blood thinner phenprocoumon? A record of the entry may be seen at Wikipedia:Did you know archive/2021/September. The nomination discussion and review may be seen at Template:Did you know nominations/Phenprocoumon.

This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:

Pharmacology Mid‑importance This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology Mid This article has been rated as Mid-importance on the project's importance scale. Medicine Mid‑importance This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine Mid This article has been rated as Mid-importance on the project's importance scale.

I have moved the following content here because it lacks context/explanation. If anyone wants to use it to improve the article, here it is. -- Ed (Edgar181) 20:38, 2 November 2015 (UTC)Reply

[[File:Phenprocoumon synthesis.svg|thumb|center|700px|Phenprocoumon synthesis:<ref>{{Cite journal | doi = 10.1007/BF00903605| title = Zur Chemie des 4-Hydroxy-cumarins| journal = Monatshefte f�r Chemie| volume = 87| pages = 218| year = 1956| last1 = Junek | first1 = H.| last2 = Ziegler | first2 = E.}}</ref><ref>{{Cite journal | doi = 10.1021/ja01569a085| title = A New Synthetic Approach to Some 3-Aralkyl-4-Hydroxycoumarins1| journal = Journal of the American Chemical Society| volume = 79| issue = 12| pages = 3291| year = 1957| last1 = Schroeder | first1 = C. H. | last2 = Titus | first2 = E. D. | last3 = Link | first3 = K. P. }}</ref><ref>{{Cite journal | doi = 10.1021/jm00239a016| title = Synthesis and thin-layer chromatographic, ultraviolet, and mass spectral properties of the anticoagulant phenprocoumon and its monohydroxylated derivatives| journal = Journal of Medicinal Chemistry| volume = 18| issue = 5| pages = 513| year = 1975| last1 = Pohl | first1 = L. R. | last2 = Haddock | first2 = R. | last3 = Garland | first3 = W. A. | last4 = Trager | first4 = W. F. }}</ref> Grüssner, Balthasar, {{US patent|2723276}} (1955 to [[Hoffmann-La Roche]]). {{US patent|2872457}} (1959 to [[WARF]]); {{Cite patent|GB|805748}} (1958 to [[Geigy]]).]]